Varex Q1 FY2025 revenue up 5% YoY to $200M; GAAP net loss $0.01/sh, Non-GAAP EPS $0.07

Varex Imaging Corp

2025-Q1 EPS reported -$0.01 revenue$199,800,000

Medical segment revenue $145M (+3% YoY); Industrial segment revenue $55M (+10% YoY).
Non-GAAP gross margin improved to 35% from 31% in prior-year quarter.
Cash flow from operations $10M; cash & securities $219M vs $213M at FY2024 year-end.
Q2 FY2025 guidance: revenue $200-215M, Non-GAAP EPS $0.05-0.20.
CEO cited solid demand and favorable sales mix driving higher-than-expected profitability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.